IL18 and neoplasm: Furthermore, it was demonstrated that IL-18 derived from tumor cells had the ability to subvert the NK cell-mediated tumor immunosurveillance and to promote tumor progression in a programed death receptor 1 (PD1)-dependent manner (240, 241).